Stay updated on NC318 Safety and Tolerability in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the results submitted for the safety and tolerability study of NC318 in subjects with advanced or metastatic solid tumors.
    Difference
    0.1%
    Check dated 2024-06-06T14:30:27.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying inclusion and exclusion criteria such as age, health status, and prior treatments. Previously, this section only indicated that no information was provided.
    Difference
    45%
    Check dated 2024-05-22T20:57:39.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T21:54:40.000Z thumbnail image

Stay in the know with updates to NC318 Safety and Tolerability in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.